Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Marbella – page 8

649 clinical trials in Marbella, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Marbella at a glance
649
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

649 trials in Marbella

Open in trial search

AUR200 for Patients with Generalized Myasthenia Gravis

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:AUR200
  • Sponsor:Aurinia Pharmaceuticals Inc.

Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Obesity

Recruiting

RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Enicepatide
  • Sponsor:F. Hoffmann-La Roche AG

Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Eli Lilly & Co.

Breast cancer+1

Recruiting

Zanidatamab, tucatinib, capecitabine or eribulin mesylate in HER2-positive advanced breast cancer in adults

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Medica Scientia Innovation Research S.L.

A study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:IKT-001PRO
  • Sponsor:Inhibikase Therapeutics Inc.

Study to evaluate the efficacy and safety of personalized tissue engineered veins in patients with severe chronic venous insufficiency

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic vein tissue segment, decellularised, with a functional valve perfused with autologous peripheral blood
  • Sponsor:VeriGraft AB

Study of K-924 (ezetimibe and pitavastatin) in patients with high cholesterol who have an inadequate response to pitavastatin

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ezetimibe
  • Sponsor:Kowa Co. Ltd.

A study of PF-08634404, ipilimumab, and axitinib in adults with advanced or metastatic kidney cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib
  • Sponsor:Pfizer Inc.

Breast cancer+1

Recruiting

Maintenance Therapy Study of Inavolisib with Pertuzumab and Trastuzumab in Patients with HER2‑Positive, PIK3CA‑Mutated Locally Advanced or Metastatic Breast Cancer

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:F. Hoffmann-La Roche AG

Phase 2 Study of Rinatabart Sesutecan with Pegfilgrastim in Adults with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Glatiramer Acetate
  • Sponsor:Genmab A/S

Study of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Belantamab Mafodotin
  • Sponsor:Glaxosmithkline Research & Development Limited

Other cities in Spain

The busiest research cities in the country

All 210 cities in Spain

Clinical research in Marbella

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on lymphomas and breast cancer treatments, including innovative combination therapies for various stages of disease progression.

  • Mantle Cell Lymphoma
  • HER2-positive Breast Cancer
  • Multiple Myeloma

Advanced clinical trials evaluating novel therapeutic combinations and targeted treatments for improved patient outcomes.

02 Respiratory Medicine

Comprehensive research into pulmonary hypertension and chronic respiratory conditions, testing new therapeutic approaches.

  • Pulmonary Arterial Hypertension
  • COPD Management
  • Asthma Treatment

Evaluation of innovative inhaler technologies and long-term treatment efficacy studies.

03 Infectious Diseases

Studies addressing various infections including herpes simplex and bacterial infections, with focus on treatment optimization.

  • Antiviral Therapies
  • Bacterial Infections
  • Candida Infections

Development of targeted immunotherapies and evaluation of treatment durations for better patient care.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.